Chief Commercial Officer at Clinical Ink
Chris Crucitti is a 20+ year seasoned life sciences and clinical services/technology executive. As chief commercial officer (CCO), Chris supports the continued growth, optimizing go-to-market strategies and building a scalable customer service approach. Prior to joining Clinical Ink, Chris most recently held the role of CCO at Signant Health, leading commercial functions for their patient-centric clinical technology solutions. Chris brings significant experience and expertise in the clinical and R&D domains, including full-service CRO, data and analytics, eClinical technology solutions, strategic resourcing, consulting, and commercial. He has a track record of leading and building teams that drive significant revenue and profitability growth while maintaining a high level of customer service and quality delivery. Chris holds a master’s from American University and a bachelor’s from Ithaca College.
Chief Commercial Officer
May, 2021 - present